Page 8 - Biofire Diagnostics News Today : Breaking News, Live Updates & Top Stories | Vimarsana

New coronavirus saliva test gets emergency approval from FDA Doctors are often left in a fix when patients complain of symptoms that are common amongst infections(generally respiratory illnesses) caused by both bacteria and viruses. This is compounded by the absence of a rudimentary tool to identify the specific disease-cause pathogen. Offering such a diagnostic tool, scientists have developed a first-of-its-kind test that can accurately differentiate between bacterial and viral infections and provide results within an hour. In a new study, researchers from Duke Health have demonstrated a t...

New testing technology can accurately differentiate between viral and bacterial infections When patients complain of coughing, runny nose, sneezing and fever, doctors are often stumped because they have no fundamental tool to identify the source of the respiratory symptoms and guide appropriate treatments. That tool might finally be on its way. In a study proving feasibility, researchers at Duke Health showed that their testing technology can accurately distinguish between a viral and a bacterial infection for respiratory illness - a critical difference that determines whether antibiotics are...

Duke University Medical Center When patients complain of coughing, runny nose, sneezing and fever, doctors are often stumped because they have no fundamental tool to identify the source of the respiratory symptoms and guide appropriate treatments. That tool might finally be on its way. In a study proving feasibility, researchers at Duke Health showed that their testing technology can accurately distinguish between a viral and a bacterial infection for respiratory illness – a critical difference that determines whether antibiotics are warranted. And, importantly, the test provided results in...

**    Duration of WHO-declared COVID-19 pandemic (a)  Wellcome Trust Publishers Pledge The first pandemic-related IP pledge addressed copyrights. On January 31, 2020, the Wellcome Trust, a large UK-based medical charity, led a group of approximately thirty scientific and medical publishers in committing to make all peer-reviewed research publications relating to COVID-19 available without charge on an open access basis. The signatories included Elsevier, Cell Press, Karger, the JAMA Network, the New England Journal of Medicine, Oxford University Press, Springer Nature, Taylor & Francis, W...

FDA authorizes marketing of first SARS-CoV-2 diagnostic test using De Novo premarket review pathway Today, the U.S. Food and Drug Administration granted marketing authorization of the BioFire Respiratory Panel 2.1 (RP2.1), a diagnostic test for the simultaneous qualitative detection and identification of multiple respiratory viral and bacterial nucleic acids in nasopharyngeal swabs (NPS) obtained from individuals suspected of COVID-19 and other respiratory tract infections. The diagnostic test, which had an Emergency Use Authorization (EUA), was granted marketing authorization using the De No...